Autologous hematopoietic stem cell transplantation conditioning regimens and chimeric antigen receptor T cell therapy in various diseases

Figure 4 Comparison of various conditioning regimens in acute myeloid leukemia. A: Comparison of leukemia free survival (LFS) and over survival (OS) between intravenous busulfan (12.8 mg/kg) combined with cyclophosphamide (120 mg/kg), melphalan (140 mg/kg), and etoposide; B: Comparison of LFS and OS between busulfan (12.8 mg/kg) plus melphalan (140 mg/kg) and busulfan (12.8 mg/kg) plus cyclophosphamide (120 mg/kg). BU: Busulfan; MEL: Melphalan; Cy: Cyclophosphamide; LFS: Leukemia free survival; OS: Over survival; BUCY: Busulfan and cyclophosphamide; BUMEL: Busulfan and melphalan.